As for CRP, Barden et al. and Cao et al.'s [11,12] studies agree that it may be a biomarker for the prediction of PE in the GDM group; Sugulle et al. [15] reported no significant difference in the DPE group. The gene discussed is CRP; the disease is gestational diabetes.